Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Detailed Description:
Additional Study Purpose Details: To assess the pharmacokinetics of metformin and PD 0332334 with concurrent administration.
On February 18th 2009, a decision to terminate further development for PD 0332334 was communicated to investigators in this study. The decision to terminate this study was not based on any safety concerns.
Age
21–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Nonsmokers
Male or female adults
You may not be if
Current or history of significant medical illness
Smokers
Illicit drug use
Clareo Health | Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time
